Our Focus

Avecia's Biologics business is one of the world's leading contract development and manufacturers of biologics for human healthcare products, with a focus on microbial-derived biologics.

From our base in the Tees Valley, in the UK, we have grown rapidly over the last five years, and invested over US$150m in state-of-the-art manufacturing facilities.

Our track record of meeting customer expectations is founded upon:

• technical and functional excellence and innovation
• dedicated project team focus
• a commitment to quality and cGMP compliance
• customer service

pAVEway™ Advanced Protein Expression

Avecia Biologics launches its new biotherapeutic protein production technology - pAVEway™. The new technology enables class-leading (>10g/L) microbial production of a wide range of therapeutically useful proteins (vaccines, cytokines, growth factors, etc). Click here for more information.